AstraZeneca to Spend $247M in Collaboration with AI Discovery Outfit Absci

By /

In the latest example of major pharma now entering AI collaborations or using AI-based tools, AstraZeneca’s deal with Absci will aim to produce an oncology candidate.

Scroll to Top